Bioventus Inc. Class A Common Stock
$12.91
$0.28 (+2.22%)
$12.34Day Range$12.99
Key Statistics
Market Cap
$881.82M
Shares Outstanding
68.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 11, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$12.49
Day High
$12.99
Day Low
$12.34
Volume
828.2K
VWAP
$12.87
Prev Close
$12.63
Transactions
--
Acc. Volume
--
About Bioventus Inc. Class A Common Stock
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841950 employees4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703(919) 474-6700IPO Feb 11, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001665988
- Composite FIGI
- BBG00D8550B3
- Share Class FIGI
- BBG00D8550C2
- Ticker Root
- BVS
- SIC Code
- 3841
About Bioventus Inc. Class A Common Stock (BVS) Stock
Bioventus Inc. Class A Common Stock (BVS) closed the 2026-09-18 session at $12.91, up 2.22% versus the previous close (+0.28). The stock opened at $12.49 and traded between $12.34 and $12.99 during that session. Session trading volume was 828K shares. The volume-weighted average price (VWAP) is $12.87.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Bioventus Inc. Class A Common Stock has a market capitalization of $881.8 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. BVS is listed on the XNAS exchange. The company employs approximately 950 people. Bioventus Inc. Class A Common Stock is headquartered in DURHAM, NC. The recorded listing date is 2021-02-11.
On this page you can find market BVS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.